Abstract

With chronic obstructive pulmonary disease (COPD) increasing in prevalence and air travel becoming progressively accessible, more and more elderly air passengers are at risk for developing severe hypoxemia and respiratory distress after cabin depressurization. To date, the gold-standard instrument used to predict the need for in-flight supplemental oxygen is the hypoxia-altitude simulation test (HAST). Unfortunately, HAST is time-intensive, invasive (it requires multiple arterial blood samples to determine PaO2), and not widely available.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call